Picture of Neximmune logo

NEXI — Neximmune News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Neximmune Inc reports results for the quarter ended in September - Earnings Summary

* Neximmune Inc  NEXI.OQ  reported a quarterly adjusted loss
of 60
cents​​ per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss
of 69 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Neximmune Inc's reported EPS for the quarter was a loss
of 60
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Neximmune Inc shares had fallen by 11.6% this quarter and
lost 89.4% so far this year.
    * The company reported a quarterly loss of $14.73 million.
    * Wall Street's median 12-month price target for Neximmune
Inc is
$3.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:22 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.69          -0.60          Beat
 Jun. 30 2022      -0.68          -0.69          Missed
 Mar. 31 2022      -0.70          -0.66          Beat
 Dec. 31 2021      -0.78          -0.69          Beat

Recent news on Neximmune

See all news